TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 151 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $655,589 | -86.4% | 73,332 | -65.8% | 0.00% | -90.0% |
Q1 2023 | $4,824,059 | +2164.8% | 214,498 | +3024.1% | 0.01% | – |
Q4 2021 | $213,000 | -83.2% | 6,866 | -86.9% | 0.00% | -100.0% |
Q3 2021 | $1,268,000 | -70.8% | 52,307 | -70.0% | 0.01% | -75.0% |
Q1 2021 | $4,349,000 | – | 174,193 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
CM Management, LLC | 60,000 | $875,000 | 0.63% |
Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |